Risankizumab Biosimilar - Research Grade
Risankizumab Biosimilar - Research Grade
Product Benefits:
ichorbio’s Risankizumab biosimilar for Research Use Only (RUO)
Target:
IL-23alpha
Size:
ichorbio’s Risankizumab biosimilar is available in the following sizes: 1mg, 5mg, 10mg, 20mg, 50mg, 100mg
Isotype:
Human IgG1(K214R/L234A/L235A/KDel)-kappa
Host:
CHO Cells
Species Reactivity:
Human
Specificity:
Detects IL-23 alpha
Purification Method:
This monoclonal antibody was purified using multi-step affinity chromatography methods such as Protein A or G depending on the species and isotype.
Concentration:
>1mg/ml
Formulation:Sterile, preservative-free, solution in PBS. BSA and Azide free.
Purity:>95% by SDS-PAGE
Endotoxin:≤ 1.0 EU/mg as determined by the LAL method
Storage:This antibody is stable for at least 4 weeks when stored at 2-8°C. For long term storage, aliquot in working volumes without diluting and store at – 20°C or -80°C. Avoid repeated freeze thaw cycles.
Applications:Functional Assays
Application Notes:This biosimilar is strictly for research use only (RUO).
Concentration | 5.41mg/ml |
---|---|
isotype | Human IgG1(K214R/L234A/L235A/KDel)-kappa |
Host | CHO Cells |